Vimarsana
Biggest News Aggregation in the World

Page 4 - Present Status News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Present Status. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Present Status Today - Breaking & Trending Today

Mustard Oil For Hair: Benefits, How To Use & More [UK] 2023 - Vimarsana News

Mustard Oil For Hair: Benefits, How To Use & More [UK] 2023

Learn about the amazing benefits of using mustard oil for hair. Find out what works best for your hair type and how to apply it effectively in 2023 .

Tagrisso plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial - Vimarsana News

Tagrisso plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial

* Results support potential for a new treatment option that builds on the benefit of first-line standard of care Tagrisso monotherapy Positive high-level results from the FLAURA2 Phase III trial... | May 17, 2023

TAGRISSO® (osimertinib) plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial - Vimarsana News

TAGRISSO® (osimertinib) plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial

Results support potential for a new treatment option that builds on the benefit of first-line standard of care TAGRISSO monotherapy ... | May 17, 2023

TAGRISSO® (osimertinib) demonstrated 5.5-year median disease-free survival in the adjuvant treatment of patients with EGFR-mutated lung cancer - Vimarsana News

TAGRISSO® (osimertinib) demonstrated 5.5-year median disease-free survival in the adjuvant treatment of patients with EGFR-mutated lung cancer

Nearly three in four patients treated with adjuvant TAGRISSO were alive and disease-free at four years Exploratory results showed TAGRISSO also reduced the risk of disease recurrence in the brain or spinal cord by 76% in patients with Stage II-IIIA disease

The 20th Major General Samir Sinha Memorial Lecture was organised by the United Service Institution (USI) of India - Vimarsana News

The 20th Major General Samir Sinha Memorial Lecture was organised by the United Service Institution (USI) of India

New Delhi [India], August 31 (ANI/PNN): The 20th Major General Samir Sinha Memorial Lecture was organised by the United Service Institution (USI) of India on 30 August 2022, wherein Air Chief Marshal VR Chaudhari, PVSM, AVSM, VM, ADC, Offg Chairman, COSC and the Chief of the Air Staff delivered a talk on 'Transformation of the Indian Air Force: Present Status and the Way Ahead. Late Maj Gen Samir Chandra Sinha, PVSM, a stalwart paratrooper, scholar and visionary, was the revered Director of the USI from November 1987 to 1996. The IAF, since its inception, has played a strategic role in our...